It is a key building block that helps create the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin, which was the first DPP-4 inhibitor approved by the FDA for type 2 diabetes treatment. (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is a crucial intermediate in the synthesis of sitagliptin, a drug used to treat type 2 diabetes.
(R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid
| API Name | Sitagliptin |
|---|---|
| CAS No | 486460-00-8 |
| Molecular Formula | C15H18F3NO4 |
| Molecular Weight | 333.30 g/mol |
| Synonyms | (3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-(2,4,5-trifluorophenyl)butanoic acid |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It is a key building block that helps create the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin, which was the first DPP-4 inhibitor approved by the FDA for type 2 diabetes treatment. (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is a crucial intermediate in the synthesis of sitagliptin, a drug used to treat type 2 diabetes.
The CAS number of (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is 486460-00-8.
The molecular formula of (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is C15H18F3NO4.
The listed molecular weight of (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is 333.30 g/mol.
(R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is listed as being used in connection with the following API: Sitagliptin.
The listed synonym or IUPAC name for (R)-3-(tert-butoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid is (3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-(2,4,5-trifluorophenyl)butanoic acid.